CRDF FY 2016 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$137M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$381,000+21.7% YoY

Gross Profit

-$1M-354.1% margin

Operating Income

-$40M-10536.7% margin

Net Income

-$39M-10289.8% margin

EPS (Diluted)

$-93.22

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$44M

Total Liabilities

$24M

Stockholders' Equity

$20M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$381,000	$313,000	+21.7%
Gross Profit	-$1M	-$316,000	-326.9%
Operating Income	-$40M	-$25M	-58.8%
Net Income	-$39M	-$27M	-42.7%